Kintor Pharmaceutical Limited
KNTPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $551,589 | $503,003 | $288,018 | $525 |
| - Cash | $52,862 | $147,419 | $322,656 | $445,499 |
| + Debt | $87,397 | $133,009 | $238,798 | $253,920 |
| Enterprise Value | $586,124 | $488,593 | $204,160 | -$191,054 |
| Revenue | $819 | $2,500 | $2,500 | $0 |
| % Growth | -67.3% | 0% | – | – |
| Gross Profit | -$1,758 | -$2,365 | -$2,365 | -$7,129 |
| % Margin | -214.8% | -94.6% | -94.6% | – |
| EBITDA | -$9,325 | -$64,185 | -$64,185 | -$847 |
| % Margin | -1,139.2% | -2,567.4% | -2,567.4% | – |
| Net Income | -$11,390 | -$77,646 | -$77,646 | -$849 |
| % Margin | -1,391.5% | -3,105.8% | -3,105.8% | – |
| EPS Diluted | -0.026 | -0.027 | -0.023 | -1.98 |
| % Growth | 2.6% | -17% | 98.8% | – |
| Operating Cash Flow | -$69,521 | -$88,419 | -$110,661 | -$174 |
| Capital Expenditures | -$900 | -$1,046 | -$492 | -$2 |
| Free Cash Flow | -$70,421 | -$89,465 | -$111,153 | -$176 |